Follow
Amir Ajoolabady
Amir Ajoolabady
Other namesJust a mediocre for now but will rise to the status I truly deserve
Scientific Thinker, Critic, Debater & Theorist - University of Alabama at Birmingham
Verified email at uab.edu - Homepage
Title
Cited by
Cited by
Year
Ferritinophagy and Ferroptosis in the Management of Metabolic Diseases
A Ajoolabady, H Aslkhodapasandhokmabad, P Libby, J Tuomilehto, ...
Trends in Endocrinology & Metabolism, 2021
1632021
Targeting Autophagy in Ischemic Stroke: from Molecular Mechanisms to Clinical Therapeutics
A Ajoolabady, S Wang, G Kroemer, JM Penninger, VN Uversky, D Pratico, ...
Pharmacology & Therapeutics, 2021
1262021
FUNDC1 Interacts with FBXL2 to Govern Mitochondrial Integrity and Cardiac Function through an IP3R3-Dependent Manner in Obesity
J Ren, M Sun, H Zhou, A Ajoolabady, Y Zhou, J Tao, JR Sowers, Y Zhang
Science Advances, 2020
872020
Endoplasmic reticulum stress in liver diseases
A Ajoolabady, N Kaplowitz, C Lebeaupin, G Kroemer, RJ Kaufman, ...
Hepatology, 2023
862023
FUNDC1 Insufficiency Sensitizes High Fat Diet Intake-Induced Cardiac Remodeling and Contractile Anomaly through ACSL4-Mediated Ferroptosis
Z Pei, Y Liu, S Liu, W Jin, Y Luo, M Sun, Y Duan, A Ajoolabady, J Sowers, ...
Metabolism, 2021
832021
Mitophagy Receptors and Mediators: Therapeutic Targets in the Management of Cardiovascular Ageing
A Ajoolabady, H Aslkhodapasandhokmabad, A Aghanejad, Y Zhang, ...
Ageing Research Reviews, 2020
722020
ER Stress and UPR in Alzheimer's Disease: Mechanisms, Pathogenesis, Treatment
A Ajoolabady, D Lindholm, J Ren, D Pratico
Cell Death & Disease - Nature, 2022
622022
Mitophagy in Cardiovascular Diseases: Molecular Mechanisms, Pathogenesis, and Treatment
A Ajoolabady, M Chiong, S Lavandero, DJ Klionsky, J Ren
Trends in Molecular Medicine, 2022
562022
ER Stress in Obesity Pathogenesis and Management
A Ajoolabady, S Liu, DJ Klionsky, GYH Lip, J Tuomilehto, S Kavalakatt, ...
Trends in Pharmacological Sciences, 2022
542022
Enzyme-Based Autophagy in Anti-Neoplastic Management: from Molecular Mechanisms to Clinical Therapeutics
A Ajoolabady, A Aghanejad, Y Bi, Y Zhang, H Aslkhodapasandhukmabad, ...
BBA-Reviews on Cancer, 2020
462020
ER Stress in Cardiometabolic Diseases: from Molecular Mechanisms to Therapeutics
A Ajoolabady, S Wang, G Kroemer, DJ Klionsky, VN Uversky, JR Sowers, ...
Endocrine Reviews, 2021
452021
S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy
N Rostami, A Nikkhoo, A Ajoolabady, G Azizi, M Hojjat-Farsangi, ...
Molecular Diagnosis & Therapy, 2019
452019
Multifunctional Nanomedicines for Targeting Epidermal Growth Factor Receptor in Colorectal Cancer
A Ajoolabady
Cellular and Molecular Life Sciences, 2020
41*2020
Inflammasome Signaling in Atrial Fibrillation: JACC State-of-the-Art Review
A Ajoolabady, S Nattel, GYH Lip, J Ren
Journal of the American College of Cardiology, 2022
392022
Dysregulation of iron metabolism in cardiovascular diseases: From iron deficiency to iron overload
Y Bi, A Ajoolabady, LJ Demillard, W Yu, ML Hilaire, Y Zhang, J Ren
Biochemical Pharmacology, 2021
382021
Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy
A Ajoolabady, D Tang, G Kroemer, J Ren
British journal of cancer - Nature, 2023
332023
Nanomedicine for Improvement of Dendritic Cell-Based Cancer Immunotherapy
V Hashemi, S Farhadi, MG Chaleshtari, B Seashore-Ludlow, A Masjedi, ...
International Immunopharmacology, 2020
312020
Chitosan-Based Nanotherapeutics for Ovarian Cancer Treatment
L Alizadeh, A Zarebkohan, R Salehi, A Ajoolabady, M Rahmati-Yamchi
Journal of Drug Targeting, 2019
272019
Targeting Autophagy in Neurodegenerative Diseases: from Molecular Mechanisms to Clinical Therapeutics
A Ajoolabady, H Aslkhodapasandhokmabad, N Henninger, LJ Demillard, ...
Clinical and Experimental Pharmacology and Physiology, 2021
262021
ER stress and inflammation crosstalk in obesity
A Ajoolabady, C Lebeaupin, NN Wu, RJ Kaufman, J Ren
Medicinal Research Reviews, 2023
232023
The system can't perform the operation now. Try again later.
Articles 1–20